8-K: Colgate-Palmolive Q2 2026 Earnings: Sales Up, EPS Mixed

Colgate-Palmolive reported a 4.9% increase in net sales and a 2.4% rise in organic sales for Q2 2026, but GAAP EPS decreased by 5% while Base Business EPS grew 8%.

Summary

• Colgate-Palmolive announced its second quarter 2026 results, with net sales increasing by 4.9% to $5,361 million and organic sales growing by 2.4%.
• GAAP diluted Earnings Per Share (EPS) decreased by 5% to $0.86, while Base Business EPS (a non-GAAP measure) increased by 8% to $0.99.
• Gross profit margin improved by 140 basis points to 61.5% on a GAAP basis and for the Base Business.
• Net cash provided by operations was $1,742 million for the first six months of 2026.
• The company maintained its full-year 2026 guidance for net sales and GAAP EPS, while updating guidance for gross profit margin and Base Business EPS.
• Global market share leadership was maintained in toothpaste (41.3% year-to-date) and manual toothbrushes (32.7% year-to-date).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive report, with solid organic sales growth and improved margins offset by a decline in GAAP EPS and continued market volatility.

Positives

• Net sales increased by 4.9% to $5,361 million in the second quarter of 2026.
• Organic sales grew by 2.4% in the second quarter, indicating underlying business strength.
• Base Business EPS increased by 8% to $0.99, showing improved operational profitability.
• GAAP Gross profit margin and Base Business Gross profit margin both increased by 140 basis points to 61.5%.
• Net cash provided by operations was strong at $1,742 million for the first six months of 2026.
• Global market share in toothpaste remains strong at 41.3% year-to-date.
• Global market share in manual toothbrushes is solid at 32.7% year-to-date.
• Full-year guidance for net sales and GAAP EPS was maintained.
• Full-year gross profit margin guidance was improved to be roughly flat (from down previously).

Negatives

• GAAP diluted EPS decreased by 5% to $0.86 in the second quarter of 2026.
• North America net sales decreased by 3.0% in the second quarter.
• North America organic sales decreased by 3.0% in the second quarter.
• North America organic volume decreased by 3.9% in the second quarter.
• Total company operating profit (GAAP) decreased by 6% to $1,016 million.
• Total company operating profit margin (GAAP) decreased by 210 basis points to 19.0%.

Risks

• Volatile market conditions are expected to continue in the balance of 2026.
• The company is exiting the private label pet food business, which has a negative impact on sales.
• Potential future challenges could arise from geopolitical events and tensions, wars, and military conflicts.
• The company's forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

Future Outlook

The company expects full-year 2026 net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange. Organic sales growth is expected to be 1% to 4%, including the impact of exiting the private label pet food business. Full-year GAAP gross profit margin is now expected to be roughly flat (revised from a previously expected decrease), and advertising is expected to increase on both a dollar basis and as a percentage of net sales, with double-digit earnings per share growth. On a non-GAAP (Base Business) basis, full-year gross profit margin is also expected to be roughly flat, advertising is expected to increase, and mid-single-digit earnings per share growth is anticipated.

Management Comments

• "Our growth momentum continued in the second quarter, as we delivered strong broad-based topand bottom-line results, despite a difficult operating environment."
• "We delivered these strong results while continuing to invest in the long-term health of our business with a 15% increase in advertising this quarter."
• "Strong levels of investment will continue in the back half of the year as we execute against our 2030 strategy with a focus on premium, science-led innovation and omni-channel demand generation to drive brand health and category growth."
• "While we expect the volatile market conditions to continue in the balance of 2026, we are confident that the strength of our global portfolio and clear business strategy should enable us to deliver consistent, compounded earnings per share growth and drive long-term shareholder value."

Industry Context

StockSavvy.ai notes that Colgate-Palmolive's performance in Q2 2026 reflects the ongoing challenges and opportunities within the global consumer staples sector, characterized by fluctuating market conditions and a continued focus on brand investment and innovation to drive growth.

Comparison to Industry Standards

• No direct comparisons to specific global benchmarks or named competitors were provided in the filing for Q2 2026 results.
• The filing does mention maintaining global market share in toothpaste and manual toothbrushes, indicating competitive strength in core categories.

Legal Proceedings

• The filing mentions charges related to the ERISA litigation matter in the reconciliation of non-GAAP financial measures.

Stakeholder Impact

• Shareholders: Continued focus on delivering consistent EPS growth and long-term shareholder value.
• Employees: Investment in advertising and innovation may support business growth and stability.
• Customers: Continued focus on product innovation and brand health.
• Suppliers: Stable demand for raw materials and components driven by sales performance.
• Creditors: Strong net cash from operations and maintained financial guidance support debt obligations.

Next Steps

• Continue investing in advertising and brand health.
• Execute the 2030 strategy focused on premium, science-led innovation and omni-channel demand generation.
• Monitor volatile market conditions throughout the remainder of 2026.
• Deliver consistent, compounded earnings per share growth and drive long-term shareholder value.

Key Dates

Recommendation

The company demonstrates resilience with organic sales growth and margin improvements in a challenging environment, and maintains full-year guidance. However, the decline in GAAP EPS and ongoing market volatility warrant a cautious 'hold' stance until clearer signs of sustained EPS growth and reduced market uncertainty emerge.

Keywords

Colgate-Palmolive, Q2 2026 Earnings, Consumer Staples, Oral Care, Pet Nutrition, Organic Sales, EPS, Gross Margin